EDGAR Filing Documents for 0000898432-19-001108

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0000898432-19-001108

Filing Date

2019-08-26

Accepted

2019-08-26 17:27:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		sc13da.htm	SC 13D/A	68735
2		exh3.htm	EX-99.3	88650
3		exh4.htm	EX-99.4	62263
4		exh5.htm	EX-99.5	168600
5		exh6.htm	EX-99.6	60359
6		csuisse.jpg	GRAPHIC	9127
	Complete submission text file	0000898432-19-001108.txt		462555

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807

Business Address (908) 947-3120

Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 191053777
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807

Business Address

Patel Gautam (Filed by) CIK: 0001738054 (see all company filings)

Type: SC 13D/A